197 related articles for article (PubMed ID: 19251086)
1. On the path to seeking novel radiosensitizers.
Katz D; Ito E; Liu FF
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):988-96. PubMed ID: 19251086
[TBL] [Abstract][Full Text] [Related]
2. Radiation sensitization with redox modulators: a promising approach.
Rosenberg A; Knox S
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):343-54. PubMed ID: 16414370
[TBL] [Abstract][Full Text] [Related]
3. [Hypoxia: a therapeutic target].
Fernández-Braña M
Clin Transl Oncol; 2005 Dec; 7(11):475-6. PubMed ID: 16373057
[No Abstract] [Full Text] [Related]
4. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
Horsman MR
Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
Weinmann M; Welz S; Bamberg M
Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
[TBL] [Abstract][Full Text] [Related]
6. A review of hypoxic cell radiosensitization.
Dische S
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):147-52. PubMed ID: 1993624
[TBL] [Abstract][Full Text] [Related]
7. GBM radiosensitizers: dead in the water…or just the beginning?
Bindra RS; Chalmers AJ; Evans S; Dewhirst M
J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in radiosensitization.
Linam J; Yang LX
Anticancer Res; 2015 May; 35(5):2479-85. PubMed ID: 25964520
[TBL] [Abstract][Full Text] [Related]
9. Modulating the radiation response.
Coleman CN
Stem Cells; 1996 Jan; 14(1):10-5. PubMed ID: 8820945
[TBL] [Abstract][Full Text] [Related]
10. Chemical radiosensitizers in cancer therapy.
Shenoy MA; Singh BB
Cancer Invest; 1992; 10(6):533-51. PubMed ID: 1422891
[TBL] [Abstract][Full Text] [Related]
11. Tumor radiosensitivity: it's the subpopulations that count.
Brown JM
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):549-50. PubMed ID: 10837934
[No Abstract] [Full Text] [Related]
12. Biologic basis for combining drugs with radiation.
Wilson GD; Bentzen SM; Harari PM
Semin Radiat Oncol; 2006 Jan; 16(1):2-9. PubMed ID: 16378901
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-directed drug strategies to target the tumor microenvironment.
Hay MP; Hicks KO; Wang J
Adv Exp Med Biol; 2014; 772():111-45. PubMed ID: 24272357
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
15. [Biological basis for concomitant chemoradiotherapy in carcinomas].
Favaudon V; Noël G
Bull Cancer; 2005 Dec; 92(12):1027-31. PubMed ID: 16396748
[TBL] [Abstract][Full Text] [Related]
16. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerase I-targeting drugs as radiation sensitizers.
Chen AY; Choy H; Rothenberg ML
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):39-46. PubMed ID: 10550825
[TBL] [Abstract][Full Text] [Related]
18. Application of Radiosensitizers in Cancer Radiotherapy.
Gong L; Zhang Y; Liu C; Zhang M; Han S
Int J Nanomedicine; 2021; 16():1083-1102. PubMed ID: 33603370
[TBL] [Abstract][Full Text] [Related]
19. [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].
Azria D; Larbouret C; Robert B; Culine S; Ychou M; Verrelle P; Dubois JB; Pèlegrin A
Bull Cancer; 2003 Nov; 90 Spec No():S202-12. PubMed ID: 14763141
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitizers: a conference preview.
Adams GE
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1181-4. PubMed ID: 6236183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
